PATENT CLAIM ANALYSIS

Application Number: 16013722
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-12
Patent Classification: ["514", "220000"]

Abstract:
Terminally sterilized, preservative-free aqueous midazolam solution comprising 0.25 to 1.5 mg/ml of midazolam, a tonicity adjusting agent to provide an osmolality of from 260 and 320 mosm/kg and sufficient acid and optionally a base to provide a pH of from about 2.5 to 3.5 with the remainder water for injection packaged in a flexible plastic container.

Claim (Index 16):
The terminally sterilized, preservative-free aqueous midazolam solution of  claim 1  wherein the Midazolam content is about 1 mg/ml, the pH is about 3, the tonicity adjusting agent is sodium chloride, and acid is hydrochloric acid.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14475206', '12647854', '13828148', '14843296', '12407551']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747927260332851
- 35 USC 102 Novelty (BERT): 0.4917101470583064
- Combined Prediction Score: 0.7464844681357872
- Mean Citation Score: 216.63536800000003
- Max Citation Score: 229.92116
- Similarity Product: 176.2638407952499

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test